• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Japan's approval of stem-cell treatment for spinal-cord injury concerns scientists.

作者信息

Cyranoski David

出版信息

Nature. 2019 Jan;565(7741):544-545. doi: 10.1038/d41586-019-00178-x.

DOI:10.1038/d41586-019-00178-x
PMID:30696963
Abstract
摘要

相似文献

1
Japan's approval of stem-cell treatment for spinal-cord injury concerns scientists.日本批准用干细胞疗法治疗脊髓损伤引发了科学家们的担忧。
Nature. 2019 Jan;565(7741):544-545. doi: 10.1038/d41586-019-00178-x.
2
Tanshinone IIA promotes the differentiation of bone marrow mesenchymal stem cells into neuronal-like cells in a spinal cord injury model.丹参酮 IIA 促进骨髓间充质干细胞向脊髓损伤模型中的神经元样细胞分化。
J Transl Med. 2018 Jul 13;16(1):193. doi: 10.1186/s12967-018-1571-y.
3
Functional recovery in spinal cord injury using mesenchymal stem cells.使用间充质干细胞促进脊髓损伤后的功能恢复。
J Control Release. 2018 May 28;278:159. doi: 10.1016/j.jconrel.2018.04.044.
4
Intrathecally Transplanting Mesenchymal Stem Cells (MSCs) Activates ERK1/2 in Spinal Cords of Ischemia-Reperfusion Injury Rats and Improves Nerve Function.鞘内移植间充质干细胞（MSCs）可激活缺血再灌注损伤大鼠脊髓中的ERK1/2并改善神经功能。
Med Sci Monit. 2016 May 2;22:1472-9. doi: 10.12659/msm.896503.
5
Mesenchymal Stem Cells for Spinal Cord Injury: Current Options, Limitations, and Future of Cell Therapy.间质干细胞治疗脊髓损伤：细胞疗法的现状、局限和未来。
Int J Mol Sci. 2019 May 31;20(11):2698. doi: 10.3390/ijms20112698.
6
Human umbilical cord mesenchymal stem cells and the treatment of spinal cord injury.人脐带间充质干细胞与脊髓损伤的治疗
Chin Med J (Engl). 2009 Jan 20;122(2):225-31.
7
Comparison of mesenchymal stem cells derived from fat, bone marrow, Wharton's jelly, and umbilical cord blood for treating spinal cord injuries in dogs.比较源自脂肪、骨髓、华通氏胶和脐带血的间充质干细胞对犬脊髓损伤的治疗效果。
J Vet Med Sci. 2012 Dec;74(12):1617-30. doi: 10.1292/jvms.12-0065. Epub 2012 Aug 9.
8
[Protective effect of transplantation of bone mesenchymal stem cells on demyelination in spinal cord injury].骨髓间充质干细胞移植对脊髓损伤脱髓鞘的保护作用
Sheng Wu Gong Cheng Xue Bao. 2018 May 25;34(5):761-776. doi: 10.13345/j.cjb.170406.
9
Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury.慢性脊髓损伤患者自体骨髓间充质干细胞移植后的安全性及神经学评估
Stem Cell Res Ther. 2014 Nov 17;5(6):126. doi: 10.1186/scrt516.
10
Electroacupuncture promotes the differentiation of transplanted bone marrow mesenchymal stem cells overexpressing TrkC into neuron-like cells in transected spinal cord of rats.电针对过表达 TrkC 的骨髓间充质干细胞向大鼠横断脊髓中神经元样细胞的分化有促进作用。
Cell Transplant. 2013;22(1):65-86. doi: 10.3727/096368912X655037. Epub 2012 Sep 21.

引用本文的文献

1
Stem cell therapies for spinal cord injury in humans: A review of recent clinical research.人类脊髓损伤的干细胞疗法：近期临床研究综述
Brain Spine. 2025 Feb 7;5:104207. doi: 10.1016/j.bas.2025.104207. eCollection 2025.
2
Stem Cell Therapies and Ageing: Unlocking the Potential of Regenerative Medicine.干细胞疗法与衰老：释放再生医学的潜力。
Subcell Biochem. 2024;107:117-128. doi: 10.1007/978-3-031-66768-8_6.
3
Mesenchymal Stromal Cell-Based Products: Challenges and Clinical Therapeutic Options.基于间充质基质细胞的产品：挑战和临床治疗选择。
Int J Mol Sci. 2024 May 31;25(11):6063. doi: 10.3390/ijms25116063.
4
CCR5-overexpressing mesenchymal stem cells protect against experimental autoimmune uveitis: insights from single-cell transcriptome analysis.过表达 CCR5 的间充质干细胞可预防实验性自身免疫性葡萄膜炎：单细胞转录组分析的见解。
J Neuroinflammation. 2024 May 27;21(1):136. doi: 10.1186/s12974-024-03134-3.
5
Mesenchymal Stem Cell (MSC)-Based Drug Delivery into the Brain across the Blood-Brain Barrier.基于间充质干细胞的药物透过血脑屏障向脑内递送
Pharmaceutics. 2024 Feb 18;16(2):289. doi: 10.3390/pharmaceutics16020289.
6
Mesenchymal Stem Cell-Induced Neuroprotection in Pediatric Neurological Diseases: Recent Update of Underlying Mechanisms and Clinical Utility.间充质干细胞诱导的儿科神经疾病神经保护：潜在机制和临床应用的最新进展。
Appl Biochem Biotechnol. 2024 Sep;196(9):5843-5858. doi: 10.1007/s12010-023-04752-y. Epub 2024 Jan 23.
7
Cell and gene therapy approvals in Japan and the need for international harmonization.日本的细胞和基因疗法批准情况以及国际协调的必要性。
Nat Biotechnol. 2024 Jan;42(1):13-17. doi: 10.1038/s41587-023-02053-7.
8
Mesenchymal Stem Cell Therapies Approved by Regulatory Agencies around the World.全球监管机构批准的间充质干细胞疗法
Pharmaceuticals (Basel). 2023 Sep 21;16(9):1334. doi: 10.3390/ph16091334.
9
Multimodal Repair of Spinal Cord Injury With Mesenchymal Stem Cells.间充质干细胞对脊髓损伤的多模态修复
Neurospine. 2022 Sep;19(3):616-629. doi: 10.14245/ns.2244272.136. Epub 2022 Sep 30.
10
Biomaterials reinforced MSCs transplantation for spinal cord injury repair.生物材料增强间充质干细胞移植用于脊髓损伤修复
Asian J Pharm Sci. 2022 Jan;17(1):4-19. doi: 10.1016/j.ajps.2021.03.003. Epub 2021 Apr 20.